Study Finds Significant Chemical Exposures in Women With Cancer
Researchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
University of California San Francisco
Give to UCSFResearchers have found that people who developed breast, ovary, skin and uterine cancers have significantly higher levels of endocrine-disrupting chemicals in their bodies.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
Babies who experience malnutrition may also experience worse cognitive development and have higher chances of death.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
An Oregon prison is testing a Norwegian-inspired approach to prison reform that’s designed to bring greater humanity to corrections and improve conditions for staff and prison residents. This includes reducing the use of solitary confinement.
Scientist proved for the first time that kidney cells, housed in an implantable device functioning as an artificial kidney, can survive inside the body of an animal.
A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.
Gal-3C, a galectin-3 inhibitor, shows promise in limiting post-MI scarring, improving cardiac function, and outperforming current therapies.
Study finds DOACs may lower recurrent VTE risk over warfarin in extended treatment. Observational evidence supports DOAC use.
A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function
Increasing wildfires means there is more wildfire smoke, which is particularly harmful for our bodies.
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Toxic dust from artificial stone slabs popular in kitchen countertops in the U.S. is causing a rising numbers in lung disease among stone workers.
UCSF study found that acute kidney injury was found in patients with chronic kidney disease.
People looking to cut back on binge drinking alcohol can take a single pill of naltrexone right before drinking to curb consumption.
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Improving predictive models with artificial intelligence may help advance diagnostics for heart disease and limit invasive testing with catheters that can be risky, especially for patients already experiencing heart and stroke issues.
In this Q&A, UCSF experts offer tips on how to stay protected during heat waves, and how to be aware of treat heat-related illnesses.